Research Article
BibTex RIS Cite

The Prevalence and Impact of Premenstrual Syndrome and Premenstrual Dysphoric Disorder On Work Performance in Turkish Employee Women

Year 2017, Volume: 48 Issue: 4, 152 - 156, 23.06.2017
https://doi.org/10.16948/zktipb.262628

Abstract




Objective:
To determine the prevalence and impact of premenstrual syndrome (PMS) and
premenstrual dysphoric disorder (PMDD) in Turkish employee women, with a focus
on their disruption of work performance.




Materials
and Methods: In this cross-sectional study, Premenstrual Symptoms Questionnaire
(PSQ) results of the 185 working women who applied to Acıbadem Kozyatagı
Hospital Gynecology Clinic between 2013-2015 with the diagnosis of
PMS/PMDD
  were analyzed.




Results:
The prevalence
  of each premenstrual
symptom was high. The
  prevalence of
moderate to severe PMS and PMDD was 11.2% and 3.9%, respectively. The
 45.7%  of
working women was found to suffer
  from reduced
work performance. 'Working as a director' (OR8.70,95%CI:1.22-120.0), 'difficulty
concentrating' (OR3.17,95%CI:1.05-10.6), and 'fatigue or lack of
 energy'(OR5.94,95%CI:1.33-34.6) increased the
risk of poor
  work performance.




Conclusions:
This study showed that premenstrual symptoms affect
  not 
only  the  daily 
activities but  also  the work performance of employee women.




References

  • 1.Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2003;28( 3):25–37.
  • 2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder—clinical procedures and research perspectives. Gynecol Endocrinol 2004;19:320–34.
  • 3.Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 1999;8:1052.
  • 4. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988;33:340–6.
  • 5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 2000. p. 771–4.
  • 6. Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008;17:113–21.
  • 7. Panay N. Management of premenstrual syndrome. J Fam Plann Reprod Health Care 2009Jul;35(3):187-94.
  • 8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Department of Health and Human Services,Washington, DC, U.S. 1994.
  • 9. Diener D, Greenstein FL, Turnbough PD. Cyclical variation in digit-span and visual-search performance in women differing in the severity of their premenstrual symptoms. Percept. Mot. Skills 1992;74: 67–76.
  • 10. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
  • 11. Dean BB, Borenstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med 2004;46:649–56.
  • 12. Gonda X, Telek T, Juhász G, Lazary J, Vargha A, Bagdy G. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008;32:1782–88.
  • 13. Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Hormones and Behavior 2008;54:85–193.
  • 14. Takeda T, Tasaka K,Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dystrophic disorder. Arch Womens Ment Health 2006;9:209.
  • 15. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating directand indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
  • 16. Dean BB, Borenstein JE. A prospective assessment investigating therelationship between work productivity and impairment with premenstrualsyndrome. J Occup Environ Med 2004;46:649–56.
  • 17. Borenstein J E, Dean BB, Leifke E, Korner P, Yonkers K A. Differences in symptom scores and health outcomes in premenstrual syndrome. Journal of Women's Health 2007;16: 1139–44.
  • 18. Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder is there an economic burden of illness. Medical Care 2002;40: 1101–12.
  • 19. Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: A putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011Nov;31(7):1183-91.

Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi

Year 2017, Volume: 48 Issue: 4, 152 - 156, 23.06.2017
https://doi.org/10.16948/zktipb.262628

Abstract




Amaç:
Çalışan Türk kadınlarında premenstruel sendrom (PMS) ve premenstruel distrofik
bozukluğun (PMDB) prevalansı ve iş performansı üzerindeki olumsuz etkisini
belirlemektir.



Gereç
ve Yöntem: Bu çapraz kesitsel çalışmada, Acıbadem Kozyatağı Hastanesi
Jinekoloji Polikliniği'ne 2013-2015 tarihleri arasında başvuran, PMS/PMDB
tanısı alan
  185 çalışan  kadına 
premensturel semptom ve etkilerini değerlendiren bir anket
uygulanmıştır.



Bulgular:
Herbir premensturel semptomun sıklığı
  yüksek
idi.
  Orta-ağır PMS ve PMDB prevalansı  sırasıyla %11.2 ve %3.9 idi. Çalışan kadınların
%45.7' i iş performansının etkilenmesinden
 şikayetçi idi. 'Yönetici konumunda çalışmak' (OO8.70,95%
GA:1.22-120.0), 'konsantrasyon güçlüğü' (OO3.17,95% GA:1.05-10.6), 'bitkinlik-enerji
yokluğu' (OO5.94,95% GA: 1.33-34.6) çalışma performansını
  olumsuz yönde arttıran risk faktörleri idi.



Sonuç:
Bu çalışma premensturel semptomların
 
sadece günlük aktiviteleri değil aynı zamanda iş performansını da  çalışan kadınlarda  olumsuz yönde 
etkilediğini göstermiştir.





References

  • 1.Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2003;28( 3):25–37.
  • 2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder—clinical procedures and research perspectives. Gynecol Endocrinol 2004;19:320–34.
  • 3.Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 1999;8:1052.
  • 4. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988;33:340–6.
  • 5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 2000. p. 771–4.
  • 6. Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008;17:113–21.
  • 7. Panay N. Management of premenstrual syndrome. J Fam Plann Reprod Health Care 2009Jul;35(3):187-94.
  • 8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Department of Health and Human Services,Washington, DC, U.S. 1994.
  • 9. Diener D, Greenstein FL, Turnbough PD. Cyclical variation in digit-span and visual-search performance in women differing in the severity of their premenstrual symptoms. Percept. Mot. Skills 1992;74: 67–76.
  • 10. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
  • 11. Dean BB, Borenstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med 2004;46:649–56.
  • 12. Gonda X, Telek T, Juhász G, Lazary J, Vargha A, Bagdy G. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008;32:1782–88.
  • 13. Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Hormones and Behavior 2008;54:85–193.
  • 14. Takeda T, Tasaka K,Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dystrophic disorder. Arch Womens Ment Health 2006;9:209.
  • 15. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating directand indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
  • 16. Dean BB, Borenstein JE. A prospective assessment investigating therelationship between work productivity and impairment with premenstrualsyndrome. J Occup Environ Med 2004;46:649–56.
  • 17. Borenstein J E, Dean BB, Leifke E, Korner P, Yonkers K A. Differences in symptom scores and health outcomes in premenstrual syndrome. Journal of Women's Health 2007;16: 1139–44.
  • 18. Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder is there an economic burden of illness. Medical Care 2002;40: 1101–12.
  • 19. Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: A putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011Nov;31(7):1183-91.
There are 19 citations in total.

Details

Subjects Health Care Administration
Journal Section Original Research
Authors

Elif Meseci

Publication Date June 23, 2017
Published in Issue Year 2017 Volume: 48 Issue: 4

Cite

APA Meseci, E. (2017). Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi. Zeynep Kamil Tıp Bülteni, 48(4), 152-156. https://doi.org/10.16948/zktipb.262628
AMA Meseci E. Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi. Zeynep Kamil Tıp Bülteni. December 2017;48(4):152-156. doi:10.16948/zktipb.262628
Chicago Meseci, Elif. “Çalışan Türk Kadınlarında Premenstruel Sendrom Ve Premenstruel Distrofik Bozukluk Prevalansı Ve İş Performansına Etkisi”. Zeynep Kamil Tıp Bülteni 48, no. 4 (December 2017): 152-56. https://doi.org/10.16948/zktipb.262628.
EndNote Meseci E (December 1, 2017) Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi. Zeynep Kamil Tıp Bülteni 48 4 152–156.
IEEE E. Meseci, “Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi”, Zeynep Kamil Tıp Bülteni, vol. 48, no. 4, pp. 152–156, 2017, doi: 10.16948/zktipb.262628.
ISNAD Meseci, Elif. “Çalışan Türk Kadınlarında Premenstruel Sendrom Ve Premenstruel Distrofik Bozukluk Prevalansı Ve İş Performansına Etkisi”. Zeynep Kamil Tıp Bülteni 48/4 (December 2017), 152-156. https://doi.org/10.16948/zktipb.262628.
JAMA Meseci E. Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi. Zeynep Kamil Tıp Bülteni. 2017;48:152–156.
MLA Meseci, Elif. “Çalışan Türk Kadınlarında Premenstruel Sendrom Ve Premenstruel Distrofik Bozukluk Prevalansı Ve İş Performansına Etkisi”. Zeynep Kamil Tıp Bülteni, vol. 48, no. 4, 2017, pp. 152-6, doi:10.16948/zktipb.262628.
Vancouver Meseci E. Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi. Zeynep Kamil Tıp Bülteni. 2017;48(4):152-6.